Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects
NCT02056210Phase 4Completed
- Sponsor
- Università di Padova
- Start
- Feb 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of plerixafor in diabetes mellitus (DM) (2 arms), sponsored by Università di Padova. Primary endpoint: CD34+ stem cell mobilization at 6 hours. Started Feb 2014; status: completed.
02
Drugs
plerixafor
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02056210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056210.